Target intelligence / Profile preview

T cell receptor beta joining 1-3 (TRBJ1-3)

Target
TRBJ1-3
Molecular classification
Other (immunoglobulin gene segment), Not a protein-encoding receptor
01

Overview

T cell receptor beta joining 1-3 (TRBJ1-3) is a **joining (J) gene segment** in the T cell receptor beta (TCRβ) locus, which participates in the **somatic recombination process** that generates the variable region of the TCRβ chain in T lymphocytes[1][3][5]. This recombination process, which also includes variable (V) and diversity (D) segments, creates the genetic diversity necessary for T cells to recognize a vast array of antigens presented by major histocompatibility complex (MHC) molecules[4][9]. The **TRBJ1-3 segment itself is not a receptor, protein, or druggable target**, but rather a genomic element involved in the assembly of TCRβ chains[1][3]. It does not have direct therapeutic targeting potential and thus is not a therapeutic target in the conventional sense[1]. Key points and clarifications: - **TRBJ1-3 is one of several J (joining) gene segments** used during **V(D)J recombination** in the thymus to generate the complementarity-determining region 3 (CDR3) of the TCRβ chain, which is critical for antigen specificity[3][4][5]. - **It is not a receptor, enzyme, transporter, or protein**, but a **genomic segment** classified within the immunoglobulin gene segments or recombination signal sequences category, often annotated as "Other" in target classification schemes. - While **essential for T cell function**, it is not independently linked to disease states except as part of the process generating TCR repertoire diversity[5]. There are no drugs known to act on this DNA segment, and it is not a therapeutic or diagnostic biomarker or candidate. - The correct entity for most drug targeting or functional antibody generation in immuno-oncology, for example, would be the **complete T cell receptor** or its protein products, not the discrete recombination segments like TRBJ1-3[1][9]. If you are looking for information about the **T cell receptor beta chain** as a functional protein complex or drug target, the entry should be for "T cell receptor beta chain" or "T cell receptor (TRB)," not the specific gene segment "TRBJ1-3"[1][9].

Other names
TRBJ1-3TRBJ13TCRBJ1S3
02

Biological functions

Generation of T cell receptor diversityAdaptive immune response
03

Disease associations

Other (role in immune recognition diversity; not direct disease association)

Beyond the preview

Go deeper on T cell receptor beta joining 1-3 (TRBJ1-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta joining 1-3 (TRBJ1-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call